Hitoshi Nakayama | OMICS International
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 312

Clinical Pharmacology & Biopharmaceutics received 312 citations as per google scholar report

Clinical Pharmacology & Biopharmaceutics peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • Publons
  • Euro Pub
Share This Page

Hitoshi Nakayama


Histone Deacetylase Inhibitor for Neurodegenerative Diseases: A Possible Medicinal Strategy by Prevention of ER Stress-Mediated Apoptosis and Induction of Neurite Elongation

Neurite outgrowth is primarily necessary step to construct a neuronal network. If this step is collapsed, neurons are died and neurodegenerative diseases, such as Alzheimer’s and Parkinson’s diseases, which are known to induce endoplasmic reticulum (ER) stress-mediated apoptosis, are occurred. It has been elucidating that histone deace... Read More»

Koji Shimoke, Takuma Tomioka, Kouta Okamoto, Daichi Fujiki, Shinichi Uesato, Hitoshi Nakayama and Toshihiko Ikeuchi

Review Article: Clin Pharmacol Biopharm 2013, S1: 006

DOI: 10.4172/2167-065X.S1-006

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF